Evaluation of Absent Pubic Hair in a 12-Year-Old
A 12-year-old with absent pubic hair requires assessment of pubertal development using Tanner staging, with particular attention to whether this represents constitutional delay or pathologic delayed puberty. 1
Initial Assessment
The evaluation hinges on determining whether this is isolated absence of pubic hair (adrenarche) versus complete absence of pubertal development:
Key Clinical Distinctions
In girls, the first sign of puberty is breast development (thelarche), not pubic hair—pubic or axillary hair (adrenarche) is not a sign of activation of the hypothalamic-pituitary-gonadal (HPG) axis. 1 Therefore, assess for:
- Breast development (Tanner staging) - this is the critical marker of pubertal onset in females 1
- Pubic hair is a secondary finding related to adrenal androgen production, not gonadal function 1
In boys, assess for:
- Testicular volume and genital development - these are the primary markers of pubertal onset 1
- Pubic hair development follows testicular enlargement 1
Tanner Staging Assessment
Assessment of pubertal stage should be performed according to Tanner stages in patients older than 10 years of age. 1 The scale defines physical development based on external primary and secondary sex characteristics, including size of breasts and genitals, testicular volume, and development of pubic hair. 1
Normal Pubertal Timing
- Girls: Normal puberty begins between 8 and 14 years of age 2
- Boys: Normal puberty begins between 9 and 14 years of age 2
At age 12, absence of any pubertal development warrants evaluation, though it may still represent constitutional delay. 2
When to Refer for Endocrine Evaluation
Endocrine evaluation is appropriate if onset of puberty is delayed beyond age 12 to 13 years. 1 Specifically:
- In girls: Absence of breast development (Tanner stage 1) at age 13 or older requires evaluation 1
- In boys: Absence of testicular enlargement at age 14 or older requires evaluation 2
Diagnostic Workup
When delayed puberty is suspected, obtain:
Laboratory Testing
- FSH, LH, and estradiol (in girls) or testosterone (in boys) as clinically indicated 1
- These hormone levels distinguish between:
- Hypergonadotropic hypogonadism (elevated FSH/LH with low sex steroids) - indicates primary gonadal failure
- Hypogonadotropic hypogonadism (low FSH/LH with low sex steroids) - indicates central/hypothalamic-pituitary dysfunction
Radiographic Assessment
- X-ray for bone age to assess growth potential and document open epiphyses 1
- Delayed bone age suggests constitutional delay; advanced or normal bone age with delayed puberty suggests pathologic cause 1
Special Considerations in Males
In boys with bilateral nonpalpable testes, immediate specialist consultation is mandatory to evaluate for disorders of sex development, including congenital adrenal hyperplasia, which can be life-threatening. 1 A newborn with a male phallus and bilateral nonpalpable gonads is potentially a genetic female (46,XX) with congenital adrenal hyperplasia until proven otherwise. 1
Differential Diagnosis
Constitutional Delay (Most Common)
Pathologic Causes Requiring Treatment
- Hypogonadotropic hypogonadism: Kallmann syndrome, pituitary disorders, chronic illness 1
- Hypergonadotropic hypogonadism: Turner syndrome (girls), Klinefelter syndrome (boys), gonadal dysgenesis 1
- Chronic systemic disease: Chronic kidney disease, malnutrition, inflammatory bowel disease 1
- Previous cancer therapy: Cranial irradiation, alkylating chemotherapy 1
Management Approach
If evaluation reveals hypogonadism, hormone replacement therapy should be offered in consultation with a pediatric endocrinologist. 1 HRT benefits include:
- Promoting pubertal progression 1
- Bone health (evaluation of bone mineral density is indicated in hypogonadal patients) 1
- Cardiovascular health 1
Constitutional delay typically requires reassurance and monitoring rather than immediate intervention, though treatment may be considered if psychological distress is significant or if there is concern about final adult height. 2